✦ LIBER ✦

A Phase I/II Study of Capecitabine Given on a Week on/Week off Schedule Combined With Bevacizumab and Oxaliplatin for Patients With Untreated Advanced Colorectal Cancer

✍ Scribed by Rajesh Sehgal; Barry C. Lembersky; Kiran K. Rajasenan; Theodore L. Crandall; Edward P. Balaban; Richard A. Pinkerton; Patrick Kane; Amy Schmotzer; Herbert Zeh; Douglas M. Potter; Ramesh K. Ramanathan

Book ID: 116365603
Publisher: CIG Media Group, LP.
Year: 2011
Tongue: English
Weight: 226 KB
Volume: 10
Category: Article
ISSN: 1533-0028
DOI: 10.1016/j.clcc.2011.03.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6058 Phase I/II study of weekly intermit

6058 Phase I/II study of weekly intermittent capecitabine with bevacizumab and oxaliplatin on an every-2-week schedule for patients with untreated advanced colorectal cancer (CRC) final results

✍ Ramanathan, R.K.; Sehgal, R.; Rajasenan, K.K.; Crandall, T.L.; Balaban, E.P.; Pi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Phase I and pharmacokinetic study of lon

Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors

✍ Carlos Castaneda; Kellen L. Meadows; Roxanne Truax; Michael A. Morse; Scott H. K 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 358 KB

A Phase I, open-label, dose escalation s

A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors

✍ John Marshall,Jimmy Hwang,Ferry A. L. M. Eskens… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 223 KB

641 POSTER A phase II trial of Capecitab

641 POSTER A phase II trial of Capecitabine (X) and Irinotecan (I) in a biweekly schedule in patients with untreated advanced colorectal cancer (ACRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 132 KB

38 POSTER Phase I and pharmacological st

38 POSTER Phase I and pharmacological study of KRN951, a potent VEGFR tyrosine kinase inhibitor given in a 4 week on, 2 week off schedule in patients with advanced solid tumors

✍ F.A.L.M. Eskens; M.J.A. de Jonge; L. van Doorn; T. Isoe; K. Hayashi; S. Hussain; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Phase I/II study of a 3-week cycle of ir

Phase I/II study of a 3-week cycle of irinotecan and S-1 in patients with advanced colorectal cancer

✍ Hitoshi Kusaba; Taito Esaki; Kitaro Futami; Sinnosuke Tanaka; Hiromitsu Fujishim 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB